List of largest biotechnology and pharmaceutical companies

Multi tool use
Multi tool use




The following is a list of the independent biotechnology companies listed on a stock exchange (as indicated) with current market capitalization of at least USD 10 billion, in decreasing order.


The list does not include biotechnology companies that are currently owned by, or a part of, larger pharmaceutical groups.




Contents






  • 1 Rankings


    • 1.1 Footnotes




  • 2 See also


  • 3 References





Rankings




































































































































































































































































































































































































Rank[N 1]
 Company
 Largest Market Cap (USD billions)
 Market Cap in Q3 2018 (USD billions)
 Market Cap in 2017 (USD billions)
 Market Cap in 2016 (USD billions)[1][2]
 Market Cap in 2015 (USD billions)[3]
 Market Cap in 2014 (USD billions)[4]
 Market Cap in 2013 (USD billions)
1 Steady
United States Johnson & Johnson[P]
NYSE: JNJ
 397.4 (Jan 2018)
 370.6 Increase
 375.4
 314.1
 284.2
 277.8
 258.3
2 Steady
United States Pfizer[P]
NYSE: PFE
 310.5 (Jul 2000)
 262.2 Increase
 215.9
 196.3
 199.3
 205.4
 196.0
3 Steady
Switzerland Roche[P]
SIX: ROG
 263.6 (Feb 2014)
 201.4 Increase
 216.7
 192.1
 234.7
 258.5
 240.3
4 Steady
Switzerland Novartis[P]
NYSE: NVS
 275.2 (Jul 2015)
 200.8 Increase
 196.7
 170.5
 206.1
 229.8
 195.0
5 Increase1
United States AbbVie[P]
NYSE: ABBV
 196.2 (Jan 2018)
 191.0 Increase
 154.4
 100.2
 96.8
 104.1
 83.8
6 Decrease1
United States Merck & Co.[P]
NYSE: MRK
 196.2 (Mar 2017)
 163.4 Increase
 153.3
 164.3
 147.6
 166.9
 146.5
7 Steady
United States Amgen[B]
NASDAQ: AMGN
 143.0 (Jan 2018)
 137.2 Increase
 126.2
 108.9
 122.5
 93.1
 78.7
8 Increase1
United States Abbott Laboratories[P]
NYSE: ABT
 129.9 (Oct 2018)
 128.6 Increase
 99.3
 56.4
 67.0
 67.9
 59.3
9 Decrease1
Denmark Novo Nordisk[P]
NYSE: NVO
 159.6 (Aug 2015)
 114.5 Increase
 131.2
 92.6
 153.9
 125.4
 19.6
10 Steady
United States Eli Lilly & Co[P]
NYSE: LLY
 125.3 (Oct 2018)
 116.5 Increase
 93.0
 80.9
 93.4
 76.6
 57.0
11 Increase1
France Sanofi[P]
NYSE: SNY
 151.3 (Sep 2014)
 111.5 Increase
 108.2
 101.8
 111.8
 138.1
 142.0
12 Increase3
United States Bristol-Myers Squibb[P]
NASDAQ: BMY
 128.3 (Jul 2016)
 101.5 Decrease
 100.3
 98.2
 114.8
 97.6
 87.2
13 Increase1
United States Gilead Sciences[B]
NASDAQ: GILD
 179.6 (Jun 2013)
 100.7 Increase
 93.6
 96.6
 145.8
 109.0
 78.4
14 Increase2
United Kingdom AstraZeneca[P]
NYSE: AZN
 102.9 (Oct 2006)
 100.2 Increase
 87.9
 68.8
 85.8
 88.9
 74.6
15 Decrease4
United Kingdom GlaxoSmithKline[P]
NYSE: GSK
 174.9 (May 2006)
 99.6 Decrease
 87.9
 93.3
 97.6
 128.9
 129.6
16 Increase2
United States Biogen[P]
NASDAQ: BIIB
 111.7 (Mar 2015)
 74.6 Increase
 67.4
 61.6
 68.3
 79.7
 66.1
17 Steady
United States Stryker Corporation[P]
NYSE: SYK
 67.2 (June 2018)
 66.4 Increase
 58.0
 45.1
 34.7
 35.7
 28.4
18 Increase2
Republic of Ireland Allergan[P]
NYSE: AGN
 133.5 (Jul 2015)
 65.9 Increase
 54.4
 72.7
 123.3
 68.5
 29.3
19 Steady
United States Celgene[B]
NASDAQ: CELG
 115.3 (Oct 2017)
 65.0 Increase
 82.2
 91.4
 94.1
 89.5
 69.2
20 Decrease10
Germany Bayer[B]
FWB: BAYN
 129.0 (Mar 2015)
 61.5 Decrease
 101.9
 85.3
 103.2
 113.2
 117.4
21 Steady
Republic of Ireland Shire Pharmaceuticals[P]
NASDAQ: SHPG
 62.0 (Sep 2014)
 55.2 Increase
 47.0
 50.1
 41.0
 42.4
 28.1
22 Increase1
United States Illumina [B]
NASDAQ: ILMN
 54.0 (Sept 2018)
 54.0 Increase
 40.2
 39.4
 35.4
 28.6
 25.7
23 Decrease1
United States Vertex Pharmaceuticals[P]
NASDAQ: VRTX
 49.1 (Sept 2018)
 49.1 Increase
 37.9
 18.3
 31.0
 28.7
 17.4
24 Steady
United States Zoetis[P]
NASDAQ: ZTS
 45.3 (Sept 2018)
 44.3 Increase
 35.1
 26.4
 23.8
 21.6
 16.3
25 Steady
United States Regeneron Pharmaceuticals Inc[P]
NASDAQ: REGN
 61.4 (Aug 2015)
 43.6 Increase
 40.4
 39.3
 56.5
 42.0
 27.4
26 Increase1
Japan Astellas[P]
TYO: 4503
 35.9 (Nov 2017)
 34.5 Increase
 29.3
 25.7
 40.6
 35.8
 27.6
27 Decrease1
Japan Takeda Pharmaceutical [P]
NASDAQ: TYO
 59.6 (June 2007)
 33.9 Decrease
 40.2
 45.6
 47.8
 37.5
 34.3
28 Steady
United States Alexion Pharmaceuticals[P]
NASDAQ: ALXN
 47.0 (Jul 2015)
 30.9 Increase
 26.7
 27.4
 43.1
 36.7
 26.0
29 Steady
Japan Daiichi Sankyo [P]
NASDAQ: DSNKY
 27.9 (June 2018)
 30.7 Increase
 27.5
 35.3
 38.8
 33.2
 28.7
30 Steady
Japan Eisai Pharmaceutical [P]
TYO: 4523
 24.7 (June 2018)
 28.8 Increase
 24.5
 37.3
 28.8
 30.2
 28.7
31 Steady
United States Mylan [P]
NASDAQ: MYL
 37.2 (Apr 2015)
 18.9 Increase
 27.5
 30.3
 38.8
 33.2
 35.7
32 Steady
United States BioMarin [P]
NASDAQ: BMRN
 24.0 (Jul 2015)
 17.4 Increase
 18.3
 20.4
 13.8
 12.9
 10.8
33 Steady
United States Incyte [P]
NASDAQ: INCY
 31.2 (Mar 2017)
 14.6 Increase
 18.3
 15.4
 10.6
 7.3
 4.6
34 Steady
United States Perrigo [P]
NASDAQ: PRGO
 29.0 (May 2017)
 10.0 Decrease
 9.9
 9.5
 8.3
 14.7
 12.2


Footnotes





  1. ^ The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice versa





  • B – Biotechnology company


  • P – Pharmaceutical company



See also


  • List of largest pharmaceutical companies by revenue


References





  1. ^ "Healthcare – Google Finance"..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ "Healthcare – Google Finance".


  3. ^ "The World's Biggest Public Companies". Forbes.


  4. ^ "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista.













zdCA3ZGI2
-
0 163JU p UhY,8XNa5ctKdCmXkY zvCWsZb tRJP1H YljPD9

Popular posts from this blog

Bressuire

Image
Subprefecture and commune in Nouvelle-Aquitaine, France Bressuire Subprefecture and commune Chateau de Bressuire and the Eglise Notre-Dame Coat of arms Location of Bressuire Bressuire Show map of France Bressuire Show map of Nouvelle-Aquitaine Coordinates: 46°50′27″N 0°29′14″W  /  46.8408°N 0.4872°W  / 46.8408; -0.4872 Coordinates: 46°50′27″N 0°29′14″W  /  46.8408°N 0.4872°W  / 46.8408; -0.4872 Country France Region Nouvelle-Aquitaine Department Deux-Sèvres Arrondissement Bressuire Canton Bressuire Government  • Mayor .mw-parser-output .nobold{font-weight:normal} (2014–20) Jean Michel Bernier Area 1 180.59 km 2 (69.73 sq mi) Population (2014) 2 19,300  • Density 110/km 2 (280/sq mi) Time zone UTC+01:00 (CET)  • Summer (DST) UTC+02:00 (CEST) INSEE/Postal code 79049 /79300 Elevation 98–236 m (322–774 ft) (avg. 173 m or 568 ft) 1 French Land Register data, which exclude...
Read more

Vorschmack

Image
Vorschmack Ukrainian Jewish-style vorschmack served on rye bread Course Hors d'oeuvre Region or state Eastern Europe Associated national cuisine Ashkenazi Jewish, Finnish, German, Ukrainian, Polish, Russian Main ingredients Ground meat and/or fish Cookbook: Vorschmack   Media: Vorschmack Vorschmack or forshmak (Yiddish: פֿאָרשמאַק ‎, from archaic German Vorschmack , "foretaste" [1] or "appetizer" [2] ) is an originally East European dish made of salty minced fish or meat. Different variants of this dish are especially common in Ashkenazi Jewish and Finnish cuisine. Some varieties are also known in Russian and Polish cuisine. Contents 1 In Jewish cuisine 2 In Russian cuisine 3 In Polish cuisine 4 In Finnish cuisine 5 See also 6 References In Jewish cuisine According to Gil Marks, the German name points to the possible Germanic origin of this dish. [1] William Pokhlyobkin descr...
Read more

Xamarin.iOS Cant Deploy on Iphone

Image
.everyoneloves__top-leaderboard:empty,.everyoneloves__mid-leaderboard:empty,.everyoneloves__bot-mid-leaderboard:empty{ height:90px;width:728px;box-sizing:border-box; } -1 I have a windows laptop and a mac mini my problem is that It wont deploy on iphone if I use Visual Studio Xamarin on windows to install my app, but it works fine with Visual Studio For Mac. Here's what I get after build succeded on Visual Studio Xamarin on windows : 1>------ Build started: Project: FinalCustomerApp.iOS, Configuration: Debug iPhone ------ 1> Connecting to Mac server 192.168.8.100... 1> FinalCustomerApp.iOS -> C:UsersJeremy PaulDesktopFinalCustomerAppFinalCustomerAppFinalCustomerApp.iOSbiniPhoneDebugFinalCustomerApp.iOS.exe 1> Detected signing identity: 1> Code Signing Key: ...
Read more